Validating deposition models in disease: What is needed?

被引:13
作者
Finlay, WH [1 ]
Lange, CF [1 ]
Li, WI [1 ]
Hoskinson, M [1 ]
机构
[1] Univ Alberta, Dept Mech Engn, Aerosol Res Lab Alberta, Edmonton, AB, Canada
来源
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG | 2000年 / 13卷 / 04期
关键词
aerosol; inhalation; simulation; scintigraphy; lung;
D O I
10.1089/jam.2000.13.381
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To develop theoretical deposition models, assumptions are introduced to make the models computationally affordable. For this reason, experimental (in vivo) validation of such models is needed to give confidence to the assumptions being made. However, for an in vivo deposition experiment to be considered useful for validation of a model, a number of parameters must be measured in the experiment for input to the model. Ideally, these parameters would include time-dependent breathing flow rates during aerosol exposure, properties of the inhaled aerosol as a function of time during the breath (including particle size distribution, aerosol mass fraction, as well as hygroscopic properties, inhaled temperature and humidity if hygroscopicity is important), in addition to anatomical regional deposition data and detailed lung geometry measurements. Furthermore, because of the dependence of extrathoracic filtering on the inlet conditions at the mouth and the complexity of modeling deposition in this region, experimental data on the filtering properties of the mouth-throat are needed. Although some of the above parameters are impractical to measure with current experimental techniques, it would greatly aid the development of deposition models if as many of these parameters as possible were measured in future in vivo deposition experiments. Data exemplifying the importance of measuring the above parameters is discussed.
引用
收藏
页码:381 / 385
页数:5
相关论文
共 19 条
[1]   MODELING THE DEPOSITION OF INHALED POWDERED DRUG AEROSOLS [J].
CLARK, AR ;
EGAN, M .
JOURNAL OF AEROSOL SCIENCE, 1994, 25 (01) :175-186
[2]  
DEHAAN WH, 1998, RESP DRUG DELIVERY, V6, P307
[3]   COMPARISON OF EXPERIMENTAL AND CALCULATED DATA FOR THE TOTAL AND REGIONAL DEPOSITION IN THE HUMAN-LUNG [J].
FERRON, GA ;
HORNIK, S ;
KREYLING, WG ;
HAIDER, B .
JOURNAL OF AEROSOL SCIENCE, 1985, 16 (02) :133-143
[4]   Estimating the type of hygroscopic behavior exhibited by aqueous droplets [J].
Finlay, WH .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1998, 11 (04) :221-229
[5]   Lung delivery of aerosolized dextran [J].
Finlay, WH ;
Lange, CF ;
King, M ;
Speert, DP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (01) :91-97
[6]  
FINLAY WH, 1998, RESP DRUG DELIVERY, V6, P235
[7]   MORPHOMETRY OF THE HUMAN PULMONARY ACINUS [J].
HAEFELIBLEUER, B ;
WEIBEL, ER .
ANATOMICAL RECORD, 1988, 220 (04) :401-414
[8]   Lung deposition of particles by airway generation in healthy subjects: Three-dimensional radionuclide imaging and numerical model prediction [J].
Hashish, AH ;
Fleming, JS ;
Conway, J ;
Halson, P ;
Moore, E ;
Williams, TJ ;
Bailey, AG ;
Nassim, M ;
Holgate, ST .
JOURNAL OF AEROSOL SCIENCE, 1998, 29 (1-2) :205-215
[9]   MONTE-CARLO MODELING OF AEROSOL DEPOSITION IN HUMAN LUNGS .2. DEPOSITION FRACTIONS AND THEIR SENSITIVITY TO PARAMETER VARIATIONS [J].
HOFMANN, W ;
KOBLINGER, L .
JOURNAL OF AEROSOL SCIENCE, 1990, 21 (05) :675-688
[10]   MONTE-CARLO MODELING OF AEROSOL DEPOSITION IN HUMAN LUNGS .3. COMPARISON WITH EXPERIMENTAL-DATA [J].
HOFMANN, W ;
KOBLINGER, L .
JOURNAL OF AEROSOL SCIENCE, 1992, 23 (01) :51-63